Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diversity
Research
Trials exclude, underdose patients with non-white blood type
People with Duffy null blood are excluded from cancer clinical trials and given lower drug doses that may be ineffective, a study found.
Darren Incorvaia
Sep 11, 2024 1:49pm
The Fierce 50 of 2024
Sep 9, 2024 5:00am
FDA releases draft guidance on clinical trial diversity
Jun 27, 2024 7:05am
Experts: To improve trial diversity, look to informed consent
May 8, 2024 2:45pm
Sponsors should embrace community-based trials: Lilly leader
Mar 20, 2024 7:00am
Masimo pulse ox is effective across skin tones, perfusion levels
Feb 12, 2024 10:35am
